Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02558348
Title Phase 1/2a Evaluation of AL3818 in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Cancer (AL3818-US-001)
Acronym AL3818
Recruitment Terminated
Gender female
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Advenchen Laboratories, LLC
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST